12:00 AM
 | 
Oct 10, 2016
 |  BC Extra  |  Company News

Nicox's eye drop gets complete response letter

Nicox S.A. (Euronext:COX) received a complete response letter from FDA for AC-170 to treat ocular itching associated with allergic conjunctivitis. The company said the letter related "solely" to a GMP...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >